Cargando…
Cause‐specific mortality after diagnosis of cancer among HIV‐positive patients: A collaborative analysis of cohort studies
People living with HIV (PLHIV) are more likely than the general population to develop AIDS‐defining malignancies (ADMs) and several non‐ADMs (NADMs). Information is lacking on survival outcomes and cause‐specific mortality after cancer diagnosis among PLHIV. We investigated causes of death within 5 ...
Autores principales: | Trickey, Adam, May, Margaret T., Gill, M. John, Grabar, Sophie, Vehreschild, Janne, Wit, Ferdinand W.N.M., Bonnet, Fabrice, Cavassini, Matthias, Abgrall, Sophie, Berenguer, Juan, Wyen, Christoph, Reiss, Peter, Grabmeier‐Pfistershammer, Katharina, Guest, Jodie L., Shepherd, Leah, Teira, Ramon, d'Arminio Monforte, Antonella, del Amo, Julia, Justice, Amy, Costagliola, Dominique, Sterne, Jonathan A.C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7187452/ https://www.ncbi.nlm.nih.gov/pubmed/32003460 http://dx.doi.org/10.1002/ijc.32895 |
Ejemplares similares
-
Parameter estimates for trends and patterns of excess mortality among persons on antiretroviral therapy in high-income European settings
por: Trickey, Adam, et al.
Publicado: (2019) -
Impact of Risk Factors for Specific Causes of Death in the First and Subsequent Years of Antiretroviral Therapy Among HIV-Infected Patients
por: Ingle, Suzanne M., et al.
Publicado: (2014) -
CD4:CD8 Ratio and CD8 Count as Prognostic Markers for Mortality in Human Immunodeficiency Virus–Infected Patients on Antiretroviral Therapy: The Antiretroviral Therapy Cohort Collaboration (ART-CC)
por: Trickey, Adam, et al.
Publicado: (2017) -
Cause-Specific Mortality in HIV-Positive Patients Who Survived Ten Years after Starting Antiretroviral Therapy
por: Trickey, Adam, et al.
Publicado: (2016) -
Mortality According to CD4 Count at Start of Combination Antiretroviral Therapy Among HIV-infected Patients Followed for up to 15 Years After Start of Treatment: Collaborative Cohort Study
por: May, Margaret T., et al.
Publicado: (2016)